Differences in muscle energy metabolism and metabolic flexibility between sarcopenic and nonsarcopenic older adults
Marni E Shoemaker, Suzette L Pereira, Vikkie A Mustad, Zachary M Gillen, Brianna D McKay, Jose M Lopez-Pedrosa, Ricardo Rueda, Joel T Cramer, Marni E Shoemaker, Suzette L Pereira, Vikkie A Mustad, Zachary M Gillen, Brianna D McKay, Jose M Lopez-Pedrosa, Ricardo Rueda, Joel T Cramer
Abstract
Background: Metabolic flexibility is the ability of skeletal muscle to adapt fuel utilization to the demand for fuel sources [carbohydrates (CHO) and fats (FAT)]. The purpose of this study was to explore muscle energy metabolism and metabolic flexibility under various conditions in sarcopenic (S) versus nonsarcopenic (NS) older adults.
Methods: Twenty-two older adults aged 65 years or older were categorized as NS [n = 11; mean ± standard deviation (SD); age = 73.5 ± 6.0 years (males, n = 5; females, n = 6)] or S [n = 11; 81.2 ± 10.5 years (males, n = 6; females, n = 5) based on handgrip strength, body composition and physical performance. Indirect calorimetry was recorded before and after consumption of a high-CHO meal and during aerobic and anaerobic exercise. Respiratory quotient (RQ), CHO and FAT oxidation were assessed. Venous blood samples were collected for glucose and insulin concentrations.
Results: At rest, compared with NS, S exhibited a 5-8% higher RQ at 0 (0.72 vs. 0.76) and 120 (0.77 vs. 0.82), 150 (0.76 vs. 0.80), and 180 min (0.74 vs. 0.80) (P = 0.002-0.025); 59-195% higher CHO oxidation at 0, 120, and 180 min (0.0004-0.002 vs. 0.001-0.002 g·min-1 ·kg-1) (P = 0.010-0.047); and 20-31% lower FAT oxidation at 0, 15, and 90-180 min (0.0009-0.0022 vs. 0.0011-0.002 g·min-1 ·kg-1 ) (P = 0.004-0.038). Glucose levels were significantly elevated in S versus NS at 0, 60 and 75 min (144.64-202.78 vs. 107.70-134.20 mg·dL-1 ) but not insulin. During aerobic exercise, RQ was 5% greater (0.90 vs. 0.86) (P = 0.039), and FAT oxidation was 35% lower at 6-8 min (0.003 vs. 0.005 g·min-1 ·kg-1 ) (P = 0.033) in S versus NS. During anaerobic exercise, CHO oxidation was 31% greater in NS versus S at 60-80% time to exhaustion (0.011 vs. 0.007 g·min-1 ·kg-1 ) (P = 0.015). Per cent contribution to energy expenditure was greater in S for CHO but lower for FAT at 0 (CHO: 22% vs. 10%; FAT: 78% vs. 91%) and 120-180 min (CHO: 35-42% vs. 17-25%; FAT: 58-65% vs. 75%-84%) (P = 0.003-0.046) at rest and 6-8 min during aerobic exercise (CHO: 70% vs. 57%; FAT: 30% vs. 45%) (P = 0.046).
Conclusions: The data show differences in skeletal muscle energy metabolism and substrate utilization between S and NS at rest, transitioning from fasted to fed state, and during exercise. Compared with NS, S displayed a diminished ability to adapt fuel utilization in response to feeding and exercise, reflecting metabolic inflexibility. Impaired metabolic flexibility could be a mechanism underlying the losses of strength and physical function accompanying sarcopenia.
Trial registration: ClinicalTrials.gov NCT03701867.
Keywords: Ageing; Carbohydrate oxidation; Exercise; Fat oxidation; Metabolic flexibility; Metabolism; Sarcopenia.
Conflict of interest statement
SLP, JMLP and RR are employees and stock holders of Abbott. VAM is a former employee of Abbott. Since 2004, the laboratory directed by JTC has received research grants from Abbott Nutrition, National Cattlemen's Beef Association, Nebraska Beef Council, Nebraska Extension, Stepan Lipid Nutrition, Rock Creek Pharmaceuticals, General Nutrition Corporation, Experimental & Applied Sciences, Nutricia, and/or the USDA National Institute for Food and Agriculture. Between 2008 and 2018, JTC served intermittently as a paid consultant for Regeneron Pharmaceuticals, Abbott Nutrition, General Nutrition Corporation, ErgoGenix/ErgoPharm, or Corr‐Jensen Labs.
© 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
Figures
References
- Cruz‐Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48:16–31.
- Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr 2006;84:475–482.
- Cruz‐Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 2014;43:748–759.
- Feher J. Muscle energetics, fatigue and training. In Quantitative Human Physiology. Academic Press; 2012. p 270–280.
- Prior SJ, Ryan AS, Stevenson TG, Goldberg AP. Metabolic inflexibility during submaximal aerobic exercise is associated with glucose intolerance in obese older adults. Obesity (Silver Spring) 2014;22:451–457.
- Goodpaster BH, Sparks LM. Metabolic flexibility in health and disease. Cell Metab 2017;25:1027–1036.
- Cermak NM, van Loon LJC. The use of carbohydrates during exercise as an ergogenic aid. Sports Med 2013;43:1139–1155.
- Defronzo RA. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 1979;28:1095–1101.
- Elahi D, Muller DC, McAloon‐Dyke M, Tobin JD, Andres R. The effect of age on insulin response and glucose utilization during four hyperglycemic plateaus. Exp Gerontol 1993;28:393–409.
- Joseph A‐M, Adhihetty PJ, Buford TW, Wohlgemuth SE, Lees HA, Nguyen LM‐D, et al. The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high‐ and low‐functioning elderly individuals. Aging Cell 2012;11:801–809.
- Young A, Stokes M, Crowe M. The size and strength of the quadriceps muscles of old and young men. Clin Physiol 1985;5:145–154.
- Roberts SB, Rosenberg I. Nutrition and aging: changes in the regulation of energy metabolism with aging. Physiol Rev 2006;86:651–667.
- American College of Sports Medicine . ACSM's Guidelines for Exercise Testing and Prescription, 10th ed. Wolters Kluwer Publishers; 2017.
- Cruz‐Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412–423.
- Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self‐reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85–M94.
- Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. Total‐body skeletal muscle mass: estimation by a new dual‐energy X‐ray absorptiometry method. Am J Clin Nutr 2002;76:378–383.
- Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889–896.
- Wier LT, Jackson AS, Ayers GW, Arenare B. Nonexercise models for estimating V˙O2max with waist girth, percent fat, or BMI. Med Sci Sports Exerc 2006;38:555–561.
- Wier LT, Ayers GW, Jackson AS, Rossum AC, Poston WS, Foreyt JP. Determining the amount of physical activity needed for long‐term weight control. Int J Obes Relat Metab Disord 2001;25:613–621.
- Reynolds JM, Gordon TJ, Robergs RA. Prediction of one repetition maximum strength from multiple repetition maximum testing and anthropometry. J Strength Cond Res 2006;20:584–592.
- Jeukendrup AE, Wallis GA. Measurement of substrate oxidation during exercise by means of gas exchange measurements. Int J Sports Med 2005;26:S28–S37.
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta‐cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
- Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462–1470.
- Senefeld J, Pereira HM, Elliott N, Yoon T, Hunter SK. Sex differences in mechanisms of recovery after isometric and dynamic fatiguing tasks. Med Sci Sports Exerc 2018;50:1070–1083.
- Nilwik R, Snijders T, Leenders M, Groen BBL, van Kranenburg J, Verdijk LB, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol 2013;48:492–498.
- McCormick R, Vasilaki A. Age‐related changes in skeletal muscle: changes to life‐style as a therapy. Biogerontology 2018;19:519–536.
- Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, et al. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol 1993;265:E380–E391.
- Goodpaster BH, Wolfe RR, Kelley DE. Effects of obesity on substrate utilization during exercise. Obes Res 2002;10:575–584.
- Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51:2944–2950.
- Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 1999;13:2051–2060.
- Muoio DM. Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock. Cell 2014;159:1253–1262.
- Hénique C, Mansouri A, Vavrova E, Lenoir V, Ferry A, Esnous C, et al. Increasing mitochondrial muscle fatty acid oxidation induces skeletal muscle remodeling toward an oxidative phenotype. FASEB J 2015;29:2473–2483.
- Rasmussen BB, Holmbäck UC, Volpi E, Morio‐Liondore B, Paddon‐Jones D, Wolfe RR. Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase‐1 activity and fat oxidation in human skeletal muscle. J Clin Invest 2002;110:1687–1693.
- Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999;277:E1130–E1141.
- Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 2009;297:E578–E591.
- Bantle JP, Laine DC, Castle GW, Thomas JW, Hoogwerf BJ, Goetz FC. Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med 1983;309:7–12.
- Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co‐morbidities. J Endocrinol 2016;229:R67–R81.
- von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021. J Cachexia Sarcopenia Muscle 2021;12:2259–2261.
Source: PubMed